Abivax SA (EURONEXT:ABVX)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ABVX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ABVX

  • Market Cap€218.620m
  • SymbolEURONEXT:ABVX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINFR0012333284

Company Profile

Abivax SA is a France based biotechnology company. It is focused on using antiviral technology platform targeting the immune system to eliminate viral diseases. The company's product is ABX 464 which is for treating HIV/AIDS. The antiviral and immunotherapeutic products that the group develops results from three technology platforms; an Antiviral platform, an Immune stimulation platform and a Polyclonal antibody platform. The Antiviral platform targets the formation of Ribonucleoprotein's in the nucleus or the cytoplasm of the infected cell during viral infection, Immune stimulation platform focuses on invariant natural killer agonists and Polyclonal antibodies platform generates neutralizing antibodies against different viruses.Abivax SA is a France based biotechnology company. It is focused on using antiviral technology platform targeting the immune system to eliminate viral diseases.

Latest ABVX news

Currently there for this company. Visit our news hub for other news .